Despite major advances in therapy, cancer continues to be a leading cause of mortality. In
addition, toxicities of traditional therapies pose a significant challenge to tolerability and …

Abstract Tumor Treating Fields (TTFields), a new modality of cancer treatment, are electric
fields transmitted transdermally to tumors. The FDA has approved TTFields for the treatment …

Abstract Tumor Treating Fields (TTFields) are low intensity, intermediate frequency,
alternating electric fields. TTFields are a unique anti-mitotic treatment modality delivered in a …

Abstract Background Tumor treating fields (TTFields) is a non-invasive, antimitotic therapy.
In the EF-14 phase 3 trial in newly diagnosed glioblastoma, TTFields plus temozolomide …

Tumor treating fields (TTFields) are low-intensity electric fields alternating at an intermediate
frequency (200kHz), which have been demonstrated to block cell division and interfere with …

Summary Background Tumor Treating Fields (TTFields) are electric fields that disrupt
processes critical for cancer cell survival, leading to immunogenic cell death and enhanced …

Glioblastoma is the most common yet most lethal of primary brain cancers with a one-year
post-diagnosis survival rate of 65% and a five-year survival rate of barely 5%. Recently the …

Simple Summary Glioblastoma (GBM) is the most common malignant primary brain tumor.
Although the standard of care, including maximal resection, concurrent radiotherapy with …

Brain tumors have been proved challenging to treat. Here, we present a promising
alternative by developing an implantable ultrasound-powered tumor treating device (UP …

Abstract Background Tumor Treating Fields (TTFields) are an anti-neoplastic treatment
modality delivered via application of alternating electric fields using insulated transducer …